Akèy › Degeneresans makile › Ohio
Etid klinik pou Degeneresans makile nan Ohio
11 etid pou Degeneresans makile ap chèche patisipan nan sit nan Ohio.
Vil nan Ohio
Tèks ofisyèl etid la (Anglè)
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
- Cincinnati Eye Institute (Site 133), Cincinnati
Ap rekriteFaz 2/3
Laj 50 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07440225A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
- Cincinnati Eye Institute, Cincinnati
- Cleveland Clinic Main Campus, Cleveland
Ap rekriteFaz 2/3
Laj 60 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT06635148A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration
- Retina Associates of Cleveland - Beachwood, Beachwood
- Retina Associates of Cleveland, Cleveland
- Retina Associates of Cleveland - Middleburg Heights, Middleburg Heights
Ap rekriteFaz 1/2
Laj 55 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT07029945A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- Cincinnati Eye Institute, Cincinnati
- University Hospitals Cleveland Medical Center, Cleveland
- The Ohio State University, Columbus
- ak 1 plis
Ap rekriteFaz 3
Laj 50 a 85 · Tout sèks · Mizajou Sep 18, 2026 · NCT06541704A Study About the Safety of a Single ASP2020 Eye Injection and if it Helps People With Vision Loss From Stargardt-type Eye Conditions
- Cincinnati Eye Institute, Cincinnati
Ap rekriteFaz 1
Laj 6 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07734064Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- Cleveland Clinic Foundation-Cole Eye Institute, Cleveland
Ap rekriteFaz 2
Laj 55 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT06659445Noninvasive Imaging Biomarkers of Treatable Macrovascular Disease in Age-related Macular Degeneration.
- Cleveland Clinic, Cleveland
Ap rekriteEtid obsèvasyon
Laj 50 a 80 · Tout sèks · Mizajou Sep 3, 2026 · NCT07798323Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
- Retina Associates of Cleveland, Beachwood
Ap rekrite
Laj 60 ak plis · Tout sèks · Mizajou Aug 26, 2026 · NCT06662162A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults
- Cincinnati Eye Institute, Cincinnati
Ap rekriteEtid obsèvasyon
Laj 6 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT07425574Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
- Cincinnati Eye Institute, Cincinnati
Ap rekriteFaz 3
Laj 50 ak plis · Tout sèks · Mizajou Apr 16, 2026 · NCT07064759Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
- Cleveland Clinic | Cole Eye Institute, Cleveland
Ap rekrite
Laj 65 ak plis · Tout sèks · Mizajou Dec 3, 2024 · NCT05438732Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.